This fact will be important in assessing any risk and benefit when the persistent peripheral avascular retina, recurrence of ROP, and incomplete regression are encountered, and may suggest that laser rather than a second anti-VEGF injection may be systemically safer. Here, VEGFA is linked to retinopathy of prematurity.